Title |
Out-of-Reference Range Thyroid-Stimulating Hormone Levels in Levothyroxine-Treated Primary Hypothyroid Patients: A Multicenter Observational Study
|
---|---|
Published in |
Frontiers in endocrinology, September 2017
|
DOI | 10.3389/fendo.2017.00215 |
Pubmed ID | |
Authors |
Dilek Gogas Yavuz, Dilek Yazıcı, Lezzan Keskin, Ayşegül Atmaca, Seda Sancak, Fulden Saraç, İbrahim Şahin, Oğuz Dikbaş, Zeliha Hekimsoy, Serap Yalın, Melin Uygur, Murat Yılmaz, Sibel Yirmibeşcik, Özlem Asmaz |
Abstract |
Although levothyroxine (LT4) replacement therapy for hypothyroidism has been established as safe, inexpensive and effective, many studies from different countries reported out-of-reference range thyroid-stimulating hormone (TSH) values for the hypothyroid patients under LT4 treatment. The aim of this study was to determine TSH levels of primary hypothyroid patients under LT4 treatment and to assess self-reported compliance with daily LT4 intake in tertiary care centers in Turkey. In this cross-sectional, observational study, adult patients with primary hypothyroidism, receiving LT4 treatment for at least 6 months, were included. The patients were from 12 tertiary care centers in 9 cities of Turkey. TSH and free T4 levels were recorded from patient files and self-reported compliance with daily LT4 intake was assessed by interviewing the subjects at the last visit. A total of 1,755 subjects (46 ± 13 years; F/M: 89.9/10.1%) with primary hypothyroidism were enrolled. Of the hypothyroid subjects, 44.8% had out-of-reference range serum TSH levels. TSH values were over the reference range (TSH > 4 mIU/L) in 26.2% and were under the reference range (TSH < 0.5 mIU/L) in 18.6% of the patients. Total duration of LT4 treatment was 5.9 ± 4.7 years and mean dose was 1.2 ± 0.6 μg/kg/day. Non-compliant patients (31.1%) had higher TSH levels (6.9 ± 16 vs 3.8 ± 0.9 mIU/L, P = 0.01) compared to compliant patients. The results of this study revealed that nearly half of the hypothyroid patients had out-of-reference range serum TSH values, despite under LT4 treatment. Compliance with LT4 treatment seems to be one of the major determinants to reach the target TSH levels in hypothyroid patients. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 24 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 6 | 25% |
Student > Master | 3 | 13% |
Other | 2 | 8% |
Student > Postgraduate | 2 | 8% |
Researcher | 2 | 8% |
Other | 2 | 8% |
Unknown | 7 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 5 | 21% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 13% |
Nursing and Health Professions | 3 | 13% |
Arts and Humanities | 2 | 8% |
Biochemistry, Genetics and Molecular Biology | 2 | 8% |
Other | 2 | 8% |
Unknown | 7 | 29% |